ARTICLE | Clinical News
Trophos reports data for muscular atrophy compound
March 11, 2014 12:50 AM UTC
Trophos S.A. (Marseille, France) said once-daily oral olesoxime ( TRO19622) prevented loss of motor function as measured by the change from baseline in Motor Function Measure (MFM) score at two years ...